Moreover, inhibiting ANXA2 expression partially reversed the effects of MMP28 on TAMs, suggesting that the MMP28-ANXA2 interaction influences TAM infiltration and polarization, thereby representing a potential therapeutic target for TAM-based pancreatic cancer treatments. The gene discussed is ANXA2; the disease is familial pancreatic carcinoma.